P425 Proactive measurement of infliximab trough levels vs. clinical management in inflammatory bowel disease: multicentre study

Autor:	M T Arroyo Villarino, S García López, C Rodríguez Gutiérrez, O. Nantes Castillejo, D Oyón Lara, A Elosua Gonzalez, P Sanz Segura
Rok vydání:	2018
Předmět:	medicine.medical_specialty business.industry Internal medicine Gastroenterology medicine General Medicine medicine.disease Trough (economics) business Inflammatory bowel disease Infliximab medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 12:S319-S320
ISSN:	1876-4479 1873-9946
DOI:	10.1093/ecco-jcc/jjx180.552
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f699eae32e212d37997ffc021843e322 https://doi.org/10.1093/ecco-jcc/jjx180.552 Zobrazit plný text záznamu